Section 1 - Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
This Specialized Disclosure Report on Form SD (the Form SD) of Cytek Biosciences, Inc. (the Company) is filed pursuant to Rule 13p-1 (the Rule) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2023 to December 31, 2023. The Rule requires disclosure of certain
information when a company manufactures or contracts to manufacture products for which the minerals specified in the Rule are necessary to the functionality or production of those products. The minerals specified in the rule are gold,
columbite-tantalite (coltan), cassiterite and wolframite, including their derivatives, which are limited to tantalum, tin, tungsten and gold (collectively, the 3TG Minerals). These requirements apply to registrants whether or not the 3TG
Minerals in their supply chain originated in the Democratic Republic of the Congo or an adjoining country (Angola, Burundi, The Central African Republic, The Republic of the Congo, Rwanda, South Sudan, Tanzania, Uganda and Zambia) (together, the
Covered Countries). As provided by applicable guidance from the U.S. Securities and Exchange Commission (the SEC) regarding the Rule, this disclosure does not address products that did not enter the stream of commerce in the
calendar year ending December 31, 2023.
The following disclosure, in response to the provisions of paragraphs (a) and (b) of Item 1.01 of Form
SD, has been made in accordance with the Updated Statement on the Effect of the Court of Appeals Decision on the Conflict Minerals Rule issued by the Division of Corporation Finance of the SEC on April 7, 2017 (the April 2017
Guidance). As permitted under the April 2017 Guidance, this Form SD does not address Item 1.01(c) of Form SD.
Conflict Minerals Disclosure
Overview
The Company is a leading cell analysis
solutions company advancing the next generation of cell analysis tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The
Companys products include flow cytometry instruments, accessories, reagents, software, and services to provide a comprehensive and integrated suite of solutions for its customers.
This Form SD relates to products of the Company (i) for which 3TG Minerals are necessary to the functionality or production of that product;
(ii) that were manufactured, or contracted to be manufactured, by the Company; and (iii) for which the manufacture was completed during 2023. These products consist of the Companys flow cytometry instruments, including the Cytek
Aurora, Northern Lights, Northern Lights CLC, Aurora CS, DxP Athena and Amnis- and Guava-branded systems for cell analysis, the Cytek Orion system for reagent cocktail preparation and sample loading systems, and related parts and accessories
(collectively, the Covered Products).
The Companys manufacturing operations are located in Fremont, California; San Diego, California;
Seattle, Washington; and Wuxi, China. The Fremont facility manufactures the Cytek Aurora and Aurora CS systems and spare parts; the San Diego facility manufactures reagents; the Seattle facility manufactures Amnis instruments and spare parts; and
the Wuxi facility manufactures the Cytek Aurora, Northern Lights, Guava and DxP Athena instruments, certain reagents and spare parts. Instruments manufactured in the Wuxi facility are delivered to the Fremont facility for final assembly and testing
from time to time.
The Companys supply chain with respect to the Covered Products is complex, and there are many third parties in the supply chain
between the original sources of 3TG Minerals and the ultimate manufacturing of the Covered Products. The Company does not purchase 3TG Minerals directly from mines, smelters or refiners and must, therefore, rely on its suppliers to provide
information regarding the origin of the 3TG Minerals that are necessary to the functionality or production of the Covered Products. The Company expects its suppliers to maintain systems of control and transparency over its mineral supply chains. The
Company is committed to conducting its business worldwide with respect for human rights and in compliance with applicable laws.
Reasonable Country of
Origin Inquiry
The Company has, in good faith and after reasonable due diligence, conducted a reasonable country of origin inquiry (RCOI)
to determine whether 3TG Minerals that are necessary to the functionality or production of its Covered Products originated in the Covered Countries, or whether any of the 3TG Minerals may have been from recycled or scrap sources.